Literature DB >> 19150978

PML3 Orchestrates the Nuclear Dynamics and Function of TIP60.

Quan Wu1, Haixiang Hu, Jianping Lan, Chibuzo Emenari, Zhiyong Wang, Kang-Sang Chang, He Huang, Xuebiao Yao.   

Abstract

The promyelocytic leukemia (PML) protein is a major component to govern the PML nuclear body (NB) assembly and function. Although it is well defined that PML NB is a site recruiting sumoylated proteins, the mechanism by which PML protein regulates the process remains unclear. Here we show that PML3, a specific PML isoform, interacts with and recruits TIP60 to PML NBs. Our biochemical characterization demonstrates that PML3 physically interacts with TIP60 via its N-terminal 364 amino acids. Importantly, this portion of TIP60 is sufficient to target to the PML NBs, suggesting that PML3-TIP60 interaction is sufficient for targeting TIP60 to the NBs. The PML3-TIP60 interaction is specific, since the region of TIP60 binding is not conserved in other PML isoforms. The physical interaction between PML3 and TIP60 protects TIP60 from Mdm2-mediated degradation, suggesting that PML3 competes with MDM2 for binding to TIP60. Fluorescence recovery after photobleaching analysis indicates that the PML3-TIP60 interaction modulates the nuclear body distribution and mobility of TIP60. Conversely, the distribution and mobility of TIP60 are perturbed in PML3-deficient cells, accompanied by aberrations in DNA damage-repairing response. Thus, PML3 orchestrates the distribution, dynamics, and function of TIP60. Our findings suggest a novel regulatory mechanism by which the PML3 and TIP60 tumor suppressors cooperate to ensure genomic stability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150978      PMCID: PMC2659233          DOI: 10.1074/jbc.M807590200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  The transcriptional role of PML and the nuclear body.

Authors:  S Zhong; P Salomoni; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

2.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.

Authors:  M Pearson; R Carbone; C Sebastiani; M Cioce; M Fagioli; S Saito; Y Higashimoto; E Appella; S Minucci; P P Pandolfi; P G Pelicci
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

Review 3.  PML protein isoforms and the RBCC/TRIM motif.

Authors:  K Jensen; C Shiels; P S Freemont
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

4.  Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation.

Authors:  Gaëlle Legube; Laetitia K Linares; Claudie Lemercier; Martin Scheffner; Saadi Khochbin; Didier Trouche
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

5.  Functional analysis and intracellular localization of p53 modified by SUMO-1.

Authors:  S S Kwek; J Derry; A L Tyner; Z Shen; A V Gudkov
Journal:  Oncogene       Date:  2001-05-03       Impact factor: 9.867

6.  Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis.

Authors:  T Ikura; V V Ogryzko; M Grigoriev; R Groisman; J Wang; M Horikoshi; R Scully; J Qin; Y Nakatani
Journal:  Cell       Date:  2000-08-18       Impact factor: 41.582

7.  Role of SUMO-1-modified PML in nuclear body formation.

Authors:  S Zhong; S Müller; S Ronchetti; P S Freemont; A Dejean; P P Pandolfi
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

8.  Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor.

Authors:  Luke Gaughan; Ian R Logan; Susan Cook; David E Neal; Craig N Robson
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

9.  Regulation of p53 activity in nuclear bodies by a specific PML isoform.

Authors:  V Fogal; M Gostissa; P Sandy; P Zacchi; T Sternsdorf; K Jensen; P P Pandolfi; H Will; C Schneider; G Del Sal
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

10.  Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Authors:  V Lallemand-Breitenbach; J Zhu; F Puvion; M Koken; N Honoré; A Doubeikovsky; E Duprez; P P Pandolfi; E Puvion; P Freemont; H de Thé
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  12 in total

1.  Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Authors:  Yunyun Geng; Shamci Monajembashi; Anwen Shao; Di Cui; Weiyong He; Zhongzhou Chen; Peter Hemmerich; Jun Tang
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  Dynamic acetylation of the kinetochore-associated protein HEC1 ensures accurate microtubule-kinetochore attachment.

Authors:  Gangyin Zhao; Yubao Cheng; Ping Gui; Meiying Cui; Wei Liu; Wenwen Wang; Xueying Wang; Mahboob Ali; Zhen Dou; Liwen Niu; Haiyan Liu; Leonard Anderson; Ke Ruan; Jingjun Hong; Xuebiao Yao
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

3.  MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Authors:  Susumu Rokudai; Oleg Laptenko; Suzzette M Arnal; Yoichi Taya; Issay Kitabayashi; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

4.  TIP60 Complex Inhibits Hepatitis B Virus Transcription.

Authors:  Hironori Nishitsuji; Saneyuki Ujino; Keisuke Harada; Kunitada Shimotohno
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers.

Authors:  P Klanrit; P Taebunpakul; M B Flinterman; E W Odell; M A Riaz; G Melino; P Salomoni; J S Mymryk; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

6.  Nuclear Arc Interacts with the Histone Acetyltransferase Tip60 to Modify H4K12 Acetylation(1,2,3).

Authors:  Caroline L Wee; Shaun Teo; Nicodemus E Oey; Graham D Wright; Hendrika M A VanDongen; Antonius M J VanDongen
Journal:  eNeuro       Date:  2014-11-12

7.  Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors.

Authors:  Nikoleta Sachini; Panagiota Arampatzi; Antonios Klonizakis; Christoforos Nikolaou; Takis Makatounakis; Eric W-F Lam; Androniki Kretsovali; Joseph Papamatheakis
Journal:  Mol Oncol       Date:  2019-05-16       Impact factor: 6.603

8.  Differential Roles of PML Isoforms.

Authors:  Sébastien Nisole; Mohamed Ali Maroui; Xavier H Mascle; Muriel Aubry; Mounira K Chelbi-Alix
Journal:  Front Oncol       Date:  2013-05-22       Impact factor: 6.244

9.  Connecting chromatin modifying factors to DNA damage response.

Authors:  Weiwei Lai; Hongde Li; Shuang Liu; Yongguang Tao
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

10.  TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy.

Authors:  Shan-Shan Gao; Hua Guan; Shuang Yan; Sai Hu; Man Song; Zong-Pei Guo; Da-Fei Xie; Yike Liu; Xiaodan Liu; Shimeng Zhang; Ping-Kun Zhou
Journal:  Sci Adv       Date:  2020-07-10       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.